Association of advanced glycation end products in Dupuytren disease
Abstract Background Advanced glycation end products are associated with aging, hyperglycemia, and oxidative stress. Accumulation of advanced glycation end products can cause various pathological conditions; however, the association of Dupuytren’s disease with advanced glycation end products has not...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13018-018-0848-4 |
_version_ | 1818036913849761792 |
---|---|
author | Fumiaki Takase Yutaka Mifune Atsuyuki Inui Yasuhiro Ueda Takeshi Kataoka Takeshi Kokubu Ryosuke Kuroda |
author_facet | Fumiaki Takase Yutaka Mifune Atsuyuki Inui Yasuhiro Ueda Takeshi Kataoka Takeshi Kokubu Ryosuke Kuroda |
author_sort | Fumiaki Takase |
collection | DOAJ |
description | Abstract Background Advanced glycation end products are associated with aging, hyperglycemia, and oxidative stress. Accumulation of advanced glycation end products can cause various pathological conditions; however, the association of Dupuytren’s disease with advanced glycation end products has not been demonstrated yet. The aim of this study is to investigate the association of Dupuytren’s disease with advanced glycation end products. Methods Normal palmar fascia from five patients with carpal tunnel syndrome (control group) and Dupuytren’s cords from five patients (Dupuytren’s disease group) were harvested. The tissues were stained using an anti-advanced glycation end products antibody, anti-receptor for advanced glycation end products antibody, and an anti-reactive oxygen species modulator 1 antibody. The expression of nicotinamide adenine dinucleotide phosphate oxidase-1 and nicotinamide adenine dinucleotide phosphate oxidase-4 genes was also assessed using real-time PCR. For in vitro analysis, the cells harvested from the control and Dupuytren’s disease groups were used. After 3 days of exposure to four types of media (control group, control + advanced glycation end products group, Dupuytren’s disease group, Dupuytren’s disease + advanced glycation end products group), superoxide detection reagent was detected using a total reactive oxygen species/superoxide detection kit. Results Immunostaining of the palmar fasciae of the Dupuytren’s disease group showed higher expressions of advanced glycation end products and receptor for advanced glycation end products than that in the control group. The expression of nicotinamide adenine dinucleotide phosphate oxidase oxidase-1 and nicotinamide adenine dinucleotide phosphate oxidase-4 as well as reactive oxygen species modulator 1, an oxidatively damaged protein, was also higher in the Dupuytren’s disease group than in the control group. In an in vitro cell culture, the addition of advanced glycation end products to the Dupuytren’s disease-derived cells produced more superoxide free radicals. Conclusions These data suggest that the advanced glycation end products receptor for advanced glycation end products interaction produced free radicals via nicotinamide adenine dinucleotide phosphate oxidase activation in Dupuytren’s disease patients. Further studies are required to confirm these results. |
first_indexed | 2024-12-10T07:18:30Z |
format | Article |
id | doaj.art-da2cc36ec1634896bc785d3405372987 |
institution | Directory Open Access Journal |
issn | 1749-799X |
language | English |
last_indexed | 2024-12-10T07:18:30Z |
publishDate | 2018-06-01 |
publisher | BMC |
record_format | Article |
series | Journal of Orthopaedic Surgery and Research |
spelling | doaj.art-da2cc36ec1634896bc785d34053729872022-12-22T01:57:53ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2018-06-011311710.1186/s13018-018-0848-4Association of advanced glycation end products in Dupuytren diseaseFumiaki Takase0Yutaka Mifune1Atsuyuki Inui2Yasuhiro Ueda3Takeshi Kataoka4Takeshi Kokubu5Ryosuke Kuroda6Department of Orthopedic Surgery, Kobe University Graduate School of MedicineDepartment of Orthopedic Surgery, Kobe University Graduate School of MedicineDepartment of Orthopedic Surgery, Kobe University Graduate School of MedicineDepartment of Orthopedic Surgery, Kobe University Graduate School of MedicineDepartment of Orthopedic Surgery, Kobe University Graduate School of MedicineDepartment of Orthopedic Surgery, Kobe University Graduate School of MedicineDepartment of Orthopedic Surgery, Kobe University Graduate School of MedicineAbstract Background Advanced glycation end products are associated with aging, hyperglycemia, and oxidative stress. Accumulation of advanced glycation end products can cause various pathological conditions; however, the association of Dupuytren’s disease with advanced glycation end products has not been demonstrated yet. The aim of this study is to investigate the association of Dupuytren’s disease with advanced glycation end products. Methods Normal palmar fascia from five patients with carpal tunnel syndrome (control group) and Dupuytren’s cords from five patients (Dupuytren’s disease group) were harvested. The tissues were stained using an anti-advanced glycation end products antibody, anti-receptor for advanced glycation end products antibody, and an anti-reactive oxygen species modulator 1 antibody. The expression of nicotinamide adenine dinucleotide phosphate oxidase-1 and nicotinamide adenine dinucleotide phosphate oxidase-4 genes was also assessed using real-time PCR. For in vitro analysis, the cells harvested from the control and Dupuytren’s disease groups were used. After 3 days of exposure to four types of media (control group, control + advanced glycation end products group, Dupuytren’s disease group, Dupuytren’s disease + advanced glycation end products group), superoxide detection reagent was detected using a total reactive oxygen species/superoxide detection kit. Results Immunostaining of the palmar fasciae of the Dupuytren’s disease group showed higher expressions of advanced glycation end products and receptor for advanced glycation end products than that in the control group. The expression of nicotinamide adenine dinucleotide phosphate oxidase oxidase-1 and nicotinamide adenine dinucleotide phosphate oxidase-4 as well as reactive oxygen species modulator 1, an oxidatively damaged protein, was also higher in the Dupuytren’s disease group than in the control group. In an in vitro cell culture, the addition of advanced glycation end products to the Dupuytren’s disease-derived cells produced more superoxide free radicals. Conclusions These data suggest that the advanced glycation end products receptor for advanced glycation end products interaction produced free radicals via nicotinamide adenine dinucleotide phosphate oxidase activation in Dupuytren’s disease patients. Further studies are required to confirm these results.http://link.springer.com/article/10.1186/s13018-018-0848-4Dupuytren’s diseaseAdvanced glycation end products (AGEs)Oxidation |
spellingShingle | Fumiaki Takase Yutaka Mifune Atsuyuki Inui Yasuhiro Ueda Takeshi Kataoka Takeshi Kokubu Ryosuke Kuroda Association of advanced glycation end products in Dupuytren disease Journal of Orthopaedic Surgery and Research Dupuytren’s disease Advanced glycation end products (AGEs) Oxidation |
title | Association of advanced glycation end products in Dupuytren disease |
title_full | Association of advanced glycation end products in Dupuytren disease |
title_fullStr | Association of advanced glycation end products in Dupuytren disease |
title_full_unstemmed | Association of advanced glycation end products in Dupuytren disease |
title_short | Association of advanced glycation end products in Dupuytren disease |
title_sort | association of advanced glycation end products in dupuytren disease |
topic | Dupuytren’s disease Advanced glycation end products (AGEs) Oxidation |
url | http://link.springer.com/article/10.1186/s13018-018-0848-4 |
work_keys_str_mv | AT fumiakitakase associationofadvancedglycationendproductsindupuytrendisease AT yutakamifune associationofadvancedglycationendproductsindupuytrendisease AT atsuyukiinui associationofadvancedglycationendproductsindupuytrendisease AT yasuhiroueda associationofadvancedglycationendproductsindupuytrendisease AT takeshikataoka associationofadvancedglycationendproductsindupuytrendisease AT takeshikokubu associationofadvancedglycationendproductsindupuytrendisease AT ryosukekuroda associationofadvancedglycationendproductsindupuytrendisease |